Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  56,571 results for ""ANTIRHEUMATIC agents""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/therapeutic use ; Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/adverse effects

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Aug 27; Vol. 83 (9), pp. 1189-1199. Date of Electronic Publication: 2024 Aug 27.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Aug 27; Vol. 83 (9), pp. 1110-1117. Date of Electronic Publication: 2024 Aug 27.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis.

  • Authors : Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Fukuoka, Japan.; Miyazaki Y

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage

  • Source: RMD open [RMD Open] 2024 Aug 22; Vol. 10 (3). Date of Electronic Publication: 2024 Aug 22.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats.

  • Authors : Hallak M; Department of Pharmacology, Institute of Health Sciences, Erciyes University, Kayseri, Turkey.; Inal A

Subjects: Hyperbaric Oxygenation*/Hyperbaric Oxygenation*/Hyperbaric Oxygenation*/methods ; Rats, Sprague-Dawley* ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2024 Aug; Vol. 51 (8), pp. e13906.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print Cited Medium: Internet ISSN: 1440-1681

Record details

Read More Add to Saved list
×
Academic Journal

Impact of treatment of rheumatoid arthritis on periodontal disease: A review.

  • Authors : Petit C; Department of Periodontology, Endodontology and Cariology, University Centre for Dental Medicine, University of Basel, Basel, Switzerland.; Dental Faculty, University of Strasbourg, Strasbourg, France.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: Molecular oral microbiology [Mol Oral Microbiol] 2024 Aug; Vol. 39 (4), pp. 199-224. Date of Electronic Publication: 2024 Feb 16.Publisher: John Wiley & Sons Country of Publication: Denmark NLM ID: 101524770 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

  • Authors : Fleischmann R; University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, Texas, USA .; Meerwein S

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/adverse effects

  • Source: RMD open [RMD Open] 2024 Jul 25; Vol. 10 (3). Date of Electronic Publication: 2024 Jul 25.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/administration & dosage

  • Source: RMD open [RMD Open] 2024 Jul 24; Vol. 10 (3). Date of Electronic Publication: 2024 Jul 24.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of methotrexate plus hydroxychloroquine combination therapy vs. methotrexate monotherapy in the treatment of rheumatoid arthritis: A randomized controlled clinical trial.

  • Authors : Ma J; Department of Rheumatology, Puyang Oilfield General Hospital, Puyang, China.; Zeng M

Subjects: Methotrexate*/Methotrexate*/Methotrexate*/adverse effects ; Methotrexate*/Methotrexate*/Methotrexate*/administration & dosage ; Methotrexate*/Methotrexate*/Methotrexate*/therapeutic use

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Sep; Vol. 27 (9), pp. e15319.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

A retrospective study of efficacy of tofacitinib combined with bDMARDs in the treatment of rheumatoid arthritis patients with inadequate response to bDMARDs.

  • Authors : Chang J; Department of Rheumatology, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.; Wang G

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Pyrimidines*/Pyrimidines*/Pyrimidines*/adverse effects

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Sep; Vol. 27 (9), pp. e15311.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management.

  • Authors : Wibrand C; Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.; Kyvsgaard N

Subjects: Methotrexate*/Methotrexate*/Methotrexate*/adverse effects ; Methotrexate*/Methotrexate*/Methotrexate*/therapeutic use ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy

  • Source: Paediatric drugs [Paediatr Drugs] 2024 Sep; Vol. 26 (5), pp. 479-498. Date of Electronic Publication: 2024 Jul 24.Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  56,571 results for ""ANTIRHEUMATIC agents""